News
A study presented at COMy 2025 shows that dual testing for minimal residual disease (MRD) using both bone marrow flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback